Most dogs with lymphoma that receive standard chemotherapy live about 12 to 16 months after diagnosis. Without any treatment, the typical survival time is only about 4 to 6 weeks. Those numbers vary significantly depending on the type of lymphoma, how far it has spread, and which treatment path you choose.
Treated vs. Untreated Survival Times
The gap between treatment and no treatment is stark. Dogs given only prednisone (a steroid used for comfort care) have a median survival of about 50 days. Prednisone can temporarily shrink lymph nodes and help a dog feel better, but it does not put the cancer into remission in a meaningful way.
Multi-drug chemotherapy protocols push that number dramatically higher. The most common approach, called the CHOP protocol, achieves complete remission in 80 to 90 percent of dogs, with median survival times of 12 to 16 months. “Median” means half of dogs live longer than that number and half live shorter. Some dogs survive two years or more, while others relapse sooner.
Why the Type of Lymphoma Matters So Much
One of the first things a veterinary oncologist will determine is whether your dog has B-cell or T-cell lymphoma. This single factor changes the prognosis more than almost anything else.
B-cell lymphoma is more common and responds better to treatment. With standard chemotherapy, dogs with B-cell lymphoma have a median survival of about 12 months. T-cell lymphoma is more stubborn. Dogs with this type typically survive 6 to 9 months with the same treatment. T-cell cases also tend to relapse earlier and are harder to push back into remission a second time.
Your vet can determine the cell type through a test called immunophenotyping, usually done on a biopsy or fine needle sample. If you’re weighing treatment options, this is one of the most useful pieces of information to have.
Intestinal and Other Non-Standard Forms
The survival numbers above apply to multicentric lymphoma, the most common form, which shows up as swollen lymph nodes throughout the body. Other forms behave quite differently.
High-grade intestinal lymphoma carries a much worse prognosis. Even with multi-drug chemotherapy, median survival is only about 62 to 77 days. However, there are important exceptions. A slower-growing subtype called small cell T-cell intestinal lymphoma responds far better to treatment, with a median survival of 628 days, roughly 21 months. Dogs with colorectal lymphoma treated with chemotherapy have done even better in some reports, with a median survival exceeding four and a half years.
These wide ranges highlight why getting a precise diagnosis matters. The word “lymphoma” covers many different diseases, and two dogs with lymphoma in the same organ can have vastly different outcomes depending on the specific cell type involved.
What Chemotherapy Looks Like for Dogs
Dog chemotherapy is designed to maintain quality of life, not to push treatment to the limits the way human oncology sometimes does. Most dogs tolerate it well. Serious side effects occur in a relatively small percentage of patients, and the drugs are dosed to minimize nausea, fatigue, and immune suppression.
The standard CHOP protocol involves a combination of drugs given through IV and oral doses over several months, typically on a weekly or biweekly schedule. Most dogs continue eating, playing, and behaving normally during treatment. When dogs do experience side effects, they’re usually mild: a day or two of reduced appetite or soft stool.
The goal of treatment is remission, not cure. Most dogs will eventually relapse, and second remissions are possible but tend to be shorter than the first. Each successive remission typically lasts about half as long as the one before it.
What Happens When Lymphoma Relapses
When lymphoma comes back after initial chemotherapy, the options narrow but don’t disappear. A second round of the same protocol can sometimes achieve remission again, though for a shorter period. Different drug combinations may also be tried.
One newer option for relapsed cases is a drug called rabacfosadine, marketed as Tanovea. In a study of 159 dogs with relapsed lymphoma, about 46 percent responded to treatment. Dogs with B-cell lymphoma at their first relapse had the best response rate at 67 percent. Those that achieved complete remission had a median progression-free interval of about four months. It’s not a long-term solution, but it can buy meaningful time for some dogs.
Factors That Influence Your Dog’s Outcome
Beyond the B-cell versus T-cell distinction, several other factors play into how long a dog is likely to live with lymphoma:
- How sick the dog is at diagnosis. Dogs that are still eating well, active, and showing no outward signs of illness (called substage “a”) tend to respond better and live longer than dogs that are already lethargic, nauseous, or losing weight at the time of diagnosis.
- How quickly remission is achieved. Dogs that reach complete remission early in treatment generally have longer survival times than those who only partially respond.
- How far the disease has spread. Lymphoma that has moved into the bone marrow or organs beyond the lymph nodes is more advanced and harder to control.
- The specific treatment chosen. Multi-drug protocols consistently outperform single-drug options. Prednisone alone provides comfort but not meaningful life extension.
Making Sense of the Numbers
Survival statistics can feel both helpful and overwhelming. It’s worth remembering that median survival times describe populations, not individual dogs. Your dog could fall anywhere on the curve. Some dogs with B-cell lymphoma live well past two years with treatment. Others relapse within a few months.
What the numbers do tell you reliably is that treatment makes a significant difference. The jump from roughly 50 days with prednisone alone to 12 to 16 months with full chemotherapy represents real time, and most of that time is good-quality life. For many owners, that’s the most important thing to know when facing this diagnosis.